HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susanne Cathcart Selected Research

Weight Loss (Weight Reduction)

1/2022Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease-results of the Immune Metabolic Associations in Psoriatic Arthritis study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susanne Cathcart Research Topics

Disease

1Weight Loss (Weight Reduction)
01/2022
1Psoriatic Arthritis
01/2022
1Body Weight (Weight, Body)
01/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022
1COVID-19
10/2020
1Shock
10/2020

Drug/Important Bio-Agent (IBA)

1Phosphodiesterase 4 InhibitorsIBA
01/2022
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
01/2022
1apremilastIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1LipidsIBA
01/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2020
1Hydrocortisone (Cortisol)FDA LinkGeneric
10/2020